Current role
Biotechnology · Healthcare
Board Member, Chairman
2024-09-09–present
Claude Nicaise, M.D.
Board Member
Filana Therapeutics, Inc. (FLNA)Chairman
Filana Therapeutics, Inc. (FLNA)Equibles does not estimate personal net worth.
Get an email with a short summary when Filana Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FLNA alertsAbout Claude Nicaise, M.D.
Claude Nicaise, M.D. is recorded as Board Member at Filana Therapeutics, Inc. (FLNA) since June 11, 2026 and Chairman at Filana Therapeutics, Inc. (FLNA) since September 9, 2024. Filana Therapeutics, Inc. reported in an 8-K filed June 15, 2026 that Claude Nicaise, M.D. was appointed Director, effective June 11, 2026. Filana Therapeutics, Inc. reported in an 8-K filed September 9, 2024 that Claude Nicaise, M.D. was appointed Chairman. Filana Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Filana Therapeutics, Inc. includes Richard (Rick) Barry (CEO), Richard J. Barry (CEO, Chairman and Board Member), Claude Nicaise (Chairman) and 7 others.
“Three (3) nominees for election or re-election to the Board of Directors were elected to serve for a three-year term, and until their successors are duly elected and qualified, based upon the following votes:”
“the Board has appointed Claude Nicaise, M.D., as its Chairman.”
Affiliation history
-
Current
2026-06-11–present
-
Current
2024-09-09–present
Company network
Leadership on record at Filana Therapeutics, Inc.
- Richard (Rick) Barry CEO
- Richard J. Barry CEO, Chairman, Board Member
- Claude Nicaise Chairman
- Eric J. Schoen CFO
- R. Christopher Cook COO, General Counsel
- Dawn C. Bir Board Member
- Dawn Carter Bir Board Member
- Dr. Claude Nicaise Board Member
- Jill M. Quigley Board Member
- Michael J. O'Donnell Board Member